GLP-1-Associated Skin Changes: Recognition and Management

The widespread use of GLP-1 receptor agonists and related anti-obesity therapies has introduced new dermatologic and aesthetic considerations. Rapid weight loss, metabolic shifts, nutritional changes, and altered body composition may contribute to facial volume loss, laxity, hair shedding, xerosis, intertrigo, and wound-healing concerns. This session offers a practical approach to recognizing these changes, distinguishing them from unrelated skin disease, and guiding patients seeking medical or cosmetic management.